Brokerages have begun breaking down the newly split entities, laying out distinct growth paths and fair value estimates for ...

The sharp decline from Wednesday's close of Rs 268.95 reflects the market's adjustment for the value of the demerged entity, ...

Due to the price adjustment post demerger, shares of Aditya Birla Fashion and Retail fell 65 per cent on Wednesday, May 22.

Samsung Biologics Co. said it plans to carve its business into a contract drug manufacturer and a holding firm which will ...

For investing inspiration, it’s a great idea to consider the latest moves of billionaires -- they’ve proven their abilities ...

Upon the effectiveness of the reverse stock split, the number of shares of the Company's outstanding common stock will decrease from approximately 35.5 million pre-split shares to approximately 2.4 ...

Penny stock below ₹10: Sarveshwar Foods share price fell over 1.25 per cent in Wednesday's trading session after the company ...

Coca-Cola Bottling Co. Consolidated (NASDAQ:COKE) is moving forward with plans to make its stock affordable to a broad range ...

The new diabetes company will be predominantly business-to-consumer, while Medtronic’s model was more business-to-business.

At the Company's special meeting of stockholders held on May 6, 2025, the Company's stockholders approved a proposal to amend the Company's Amended and Restated Certificate of Incorporation to effect ...

Aditya Birla Fashion and Retail Ltd (ABFRL) has demerged into two listed entities—ABFRL and ABLBL—effective May 22, 2025.

Medtronic bumped up its dividend payout and unveiled plans to spin off its diabetes business as the medical-device company targeted revenue growth for the new fiscal year of roughly 5%.